Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer (MPM)

Multicolour Versus Monocolour Inking Specimens After Pancreaticoduodenectomy for Periampullary Cancer: a Single Center Prospective Randomised Clinical Trial.

A single-centre, randomised clinical trial of patients affected by periampullary cancer who underwent pancreaticoduodenectomies which included two different types of specimen margination: arm A (multicolour inking) and arm B (monocolour inking). The randomisation of the specimen was made after the resection, blinded for the surgeons involved in the operation. The primary endpoint was the overall R1 resection rate and its difference between the two arms. The secondary endpoints were the R1 resection rate in each margin and its difference between the two arms, and the impact of margin status on survival. A sample size of 18 patients was required.

Study Overview

• Status: Completed
• Conditions: Periampullary Cancer; Neoplasm, Residual; Pancreatic Neoplasm; Stage, Pancreatic Cancer
• Intervention / Treatment: Procedure: Multicolour inking specimens; Procedure: Monocolour inking specimens

Detailed Description

This study was a single-centre, prospective, controlled, open, parallel group, randomised clinical trial, conducted in the tertiary referral University Centre of S.Orsola-Malpighi Hospital, Bologna, Italy, from June 2012 to January 2016, which enrolled patients affected by periampullary cancer who underwent pancreaticoduodenectomy (PD). All patients with suspected periampullary cancer were enrolled in the study, but only patients who underwent pancreaticoduodenectomy were randomised and allocated to a multicolour inking specimen (arm A, experimental) or a monocolour inking (arm B, control) after specimen was taken out from the operative field. The analysis regarded only the specimens of the patients who underwent PD in which the final pathologic report showed a diagnosis of invasive periampullary cancer (pancreatic, ampullary and distal bile duct).

After performing the pancreaticoduodenectomies, the surgeon intraoperatively inked the surfaces/margins of the specimen with different colours. In the multicolour arm, the surfaces/margins inked were the following: Anterior surface of the pancreas (yellow); Posterior surface of the pancreas (orange); Superior mesenteric/portal vein groove (blu); Superior mesenteric artery margin (retroperitoneal margin) (red); Transection margin of the bile duct (green).The trans-section pancreatic and gastric margins were not inked.

In the monocolour arm, only the superior mesenteric artery margin and the pancreatic margin were intraoperatively indicated by the surgeon in the specimen: a single stitch to identify the transection pancreatic margin and a continuous suture to identify the superior mesenteric artery margin. Monochromatic inking of the superior mesenteric artery margin was subsequently carried out by the pathologist. In both arms of treatment, the macroscopic evaluation and slicing of the surgical specimen followed the Leeds Pathology Protocol (LEEPP), and seven margins, which included the anterior, posterior, superior mesenteric /portal vein groove, superior mesenteric artery, bile duct, pancreatic neck and stomach margins, were examined. The primary endpoint was to evaluate the overall R1 resection rate and its difference between multicolour (arm A) and monocolour (arm B) inking of the specimen. The secondary endpoints were to evaluate the R1 resection rate in each margin: anterior and posterior surfaces of the pancreatic head; superior mesenteric/portal vein groove; superior mesenteric artery margin; transection pancreatic and bile duct margins, and its difference between the two arms compared. Finally, the impact of the margin status on survival was considered for each margin and type of periampullary tumours.

Calculation of the sample size was based on the literature assumption that the overall incidence rate expected of R1 ranged from 10 to 76% while it increased to 81-85% when a standardised pathological technique and margination with multicolour inking, as described in arm A, was performed. To detect a difference in R1 rate between these values with a 5% alpha-error and a 80% beta-error at a two-sided 0.05 significance level, a sample size of 18 patients was required for each group. In relation to the fact that the patients were often randomised without a preoperative biopsy, and that following current literature the 5-13% of the presumed malignancies were benign, it was decided to randomise 25 patients in order to avoid a sample size smaller than expected. The sample size calculation was carried out using PS Power and Sample Size Calculation software (Department of Biostatistics; Vanderbilt University; Nashville, TN, USA).

• Study Type: Interventional
• Enrollment (Actual): 68
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Italy
  • Bologna, Italy, 40138
    • S.Orsola-Malpighi Hospital, University of Bologna

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• medical history without previous pancreatic resection or pancreatic cancer
• written consent

Exclusion Criteria:

• patients previously treated with chemotherapy radiotherapy or chemoradiotherapy for pancreatic cancer
• patients with diagnostic doubts of chronic pancreatitis, serous cystic tumours, intraductal papillary mucinous tumours or neuroendocrine tumours
• patients unresectable at laparotomy
• patients who had undergone other pancreatic resections (total or subtotal pancreatectomy).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Arm A-Multicolour inking specimen; After performing the pancreaticoduodenectomies, the surgeon intraoperatively inked the surfaces/margins of the specimen with different colours. The surfaces/margins inked were the following: Anterior surface of the pancreas (yellow);; Posterior surface of the pancreas (orange);; Superior mesenteric/portal vein groove (blu);; Superior mesenteric artery margin (retroperitoneal margin) (red);; Transection margin of the bile duct (green) The trans-section pancreatic and gastric margins were not inked.	Procedure: Multicolour inking specimens
Other: Arm B-Monocolour inking specimen; In arm B, only the superior mesenteric artery margin and the pancreatic margin were intraoperatively indicated by the surgeon in the specimen: a single stitch to identify the transection pancreatic margin and a continuous suture to identify the superior mesenteric artery margin. Monochromatic inking of the superior mesenteric artery margin was subsequently carried out by the pathologist.	Procedure: Monocolour inking specimens

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evaluate overall microscopic resection margins involvement (R1 rate) after pancreaticoduodenectomy for periampullary cancer.	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Evaluate R1 rate differences between multicolour and monocolour inking of the specimen	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evaluate R1 resection rate in anterior surface of the pancreatic head.	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Evaluate R1 resection rate in posterior surface of the pancreatic head.	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Evaluate R1 resection rate in superior mesenteric/portal vein groove	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Evaluate R1 resection rate in superior mesenteric artery margin	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Evaluate R1 resection rate in pancreatic transection margin	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Evaluate R1 resection rate in common bile duct margin	Microscopic margin involvement (R1) was defined as a distance of the tumour from the resection margin of ≤1 mm.	At the time of pathological examination
Disease Free Survival and Overall Survival of the participants	Disease Free Survival and Overall Survival of the participants are measured using Kaplan-Meier curves.	Through study completion, an average of 6 months
Relation between Disease Free Survival and Overall Survival of the participants and R status	Disease Free Survival and Overall Survival of the participants are measured using Kaplan-Meier curves and divided in subgroups related to their margin status (R0 versus R1).	Through study completion, an average of 6 months

Collaborators and Investigators

• Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Investigators: Principal Investigator: Riccardo Casadei, Professor, S. Orsola-Malpighi Hospita, University of Bologna, Italy

Study record dates

Study Major Dates

• Study Start: June 1, 2012
• Primary Completion (Actual): January 1, 2016
• Study Completion (Actual): January 1, 2016

Study Registration Dates

• First Submitted: September 1, 2016
• First Submitted That Met QC Criteria: September 9, 2016
• First Posted (Estimate): September 15, 2016

Study Record Updates

• Last Update Posted (Estimate): September 15, 2016
• Last Update Submitted That Met QC Criteria: September 9, 2016
• Last Verified: September 1, 2016

More Information

Terms related to this study

• Keywords: cancer; pancreas; resection margin; pathology
• Additional Relevant MeSH Terms: Digestive System Diseases; Pathologic Processes; Neoplasms by Site; Endocrine System Diseases; Digestive System Neoplasms; Endocrine Gland Neoplasms; Neoplastic Processes; Pancreatic Diseases; Neoplasms; Pancreatic Neoplasms; Neoplasm, Residual
• Other Study ID Numbers: MPM-DCP

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO